PTC Therapeutics faces pivotal FDA decisions for approvals that could potentially transform their long-term revenues. Click ...

OH and the leaf of the kratom plant are not analogous, but as the former is a derivative of the latter, it has opioid-like qualities that make its susceptibility to abuse concerning.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is a biotechnology company specializing in RNA interference (RNAi) therapeutics ...

The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.

Indian-origin scientist Vinay Prasad resigned as the FDA's vaccine and gene therapy chief in just three months after backlash ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second ...

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...

On Dr. Prasad’s new watch, the FDA has torpedoed several promising treatments for rare and deadly diseases. This includes an immunotherapy shot that helped a third of advanced melanoma patients who ...

Donald Trump reportedly ignored calls from Health Secretary Robert F. Kennedy Jr. not to fire the top vaccine official at the ...

Other changes under Prasad, who was also the agency's chief medical and science officer, included a new policy limiting the ...

The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.